Supernus Pharmaceuticals, Inc. (SUPN)
50.59
+0.05
(+0.10%)
USD |
NASDAQ |
Apr 07, 13:24
Supernus Pharmaceuticals Price : 50.59 for April 7, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 173.66 |
| BridgeBio Pharma, Inc. | 71.37 |
| Corcept Therapeutics, Inc. | 41.60 |
| Catalyst Pharmaceuticals, Inc. | 25.04 |
| Cytokinetics, Inc. | 65.51 |
Price Related Metrics
| PS Ratio | 3.988 |
| Price to Book Value | 2.747 |
| Price to Free Cash Flow | 62.33 |
| Earnings Yield | -1.35% |
| Market Cap | 2.913B |